101 related articles for article (PubMed ID: 24929642)
1. Volume of high-dose regions and likelihood of locoregional control after perioperative high-dose-rate brachytherapy: do hotter implants work better?
Martínez-Monge R; Cambeiro M; Ramos LI; Olarte A; Valtueña G; San-Julián M; Alcalde J; Naval-Gías L; Jurado M
Brachytherapy; 2014; 13(6):591-6. PubMed ID: 24929642
[TBL] [Abstract][Full Text] [Related]
2. A proposal for the stratification of the risk of locoregional failure after surgical resection, perioperative high dose rate brachytherapy, and external beam irradiation: the University of Navarre predictive model.
Martínez-Monge R; Cambeiro M; Rodríguez-Ruiz ME; Ramos LI; San-Julián M; Alcalde J; Jurado M
Brachytherapy; 2014; 13(4):400-4. PubMed ID: 24295964
[TBL] [Abstract][Full Text] [Related]
3. Time to loading and locoregional control in perioperative high-dose-rate brachytherapy: The tumor bed effect revisited.
Martínez-Monge R; Valtueña G; Santisteban M; Cambeiro M; Arbea L; Ramos LI; Olarte A; San-Julián M; Alcalde J; Naval-Gías L; Jurado M
Brachytherapy; 2015; 14(4):565-70. PubMed ID: 25920811
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of Perioperative High Dose Rate Brachytherapy (PHDRB) and external beam radiation in adult patients with soft tissue sarcomas of the extremities and the superficial trunk: Final results of a prospective controlled study.
Gimeno M; San Julián M; Cambeiro M; Arbea L; Jablonska P; Moreno-Jiménez M; Amillo S; Aristu J; Lecanda F; Martinez-Monge R
Radiother Oncol; 2019 Jun; 135():91-99. PubMed ID: 31015176
[TBL] [Abstract][Full Text] [Related]
5. Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Initial results of a Phase I/II reirradiation study.
Martínez-Monge R; Alcalde J; Concejo C; Cambeiro M; Garrán C
Brachytherapy; 2006; 5(1):32-40. PubMed ID: 16563995
[TBL] [Abstract][Full Text] [Related]
6. Perioperative high-dose-rate brachytherapy in soft tissue sarcomas of the extremity and superficial trunk in adults: initial results of a pilot study.
Martínez-Monge R; San Julián M; Amillo S; Cambeiro M; Arbea L; Valero J; González-Cao M; Martín-Algarra S
Brachytherapy; 2005; 4(4):264-70. PubMed ID: 16344256
[TBL] [Abstract][Full Text] [Related]
7. Determinants of toxicity, patterns of failure, and outcome among adult patients with soft tissue sarcomas of the extremity and superficial trunk treated with greater than conventional doses of perioperative high-dose-rate brachytherapy and external beam radiotherapy.
San Miguel I; San Julián M; Cambeiro M; Fernández Sanmamed M; Vázquez-García B; Pagola M; Gaztañaga M; Martín-Algarra S; Martinez-Monge R
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e529-39. PubMed ID: 21665380
[TBL] [Abstract][Full Text] [Related]
8. Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (PHDRB).
Martínez-Monge R; Pagola Divassón M; Cambeiro M; Gaztañaga M; Moreno M; Arbea L; Montesdeoca N; Alcalde J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e245-54. PubMed ID: 21620582
[TBL] [Abstract][Full Text] [Related]
9. Salvage wide resection with intraoperative electron beam therapy or HDR brachytherapy in the management of isolated local recurrences of soft tissue sarcomas of the extremities and the superficial trunk.
Cambeiro M; Aristu JJ; Moreno Jimenez M; Arbea L; Ramos L; San Julian M; Azinovic I; Calvo FA; Martínez-Monge R
Brachytherapy; 2015; 14(1):62-70. PubMed ID: 25443530
[TBL] [Abstract][Full Text] [Related]
10. Interaction of 2-Gy equivalent dose and margin status in perioperative high-dose-rate brachytherapy.
Martínez-Monge R; Cambeiro M; Moreno M; Gaztañaga M; San Julián M; Alcalde J; Jurado M
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1158-63. PubMed ID: 21353160
[TBL] [Abstract][Full Text] [Related]
11. Perioperative high dose rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Results of a phase I/II reirradiation study.
Martínez-Fernández MI; Alcalde J; Cambeiro M; Peydró GV; Martínez-Monge R
Radiother Oncol; 2017 Feb; 122(2):255-259. PubMed ID: 27745912
[TBL] [Abstract][Full Text] [Related]
12. Phase I-II trial of perioperative high-dose-rate brachytherapy in oral cavity and oropharyngeal cancer.
Martínez-Monge R; Gómez-Iturriaga A; Cambeiro M; Garrán C; Montesdeoca N; Aristu JJ; Alcalde J
Brachytherapy; 2009; 8(1):26-33. PubMed ID: 19041280
[TBL] [Abstract][Full Text] [Related]
13. Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial.
Martínez-Monge R; Valtueña Peydró G; Cambeiro M; Aramendía JM; Gimeno M; Santisteban M; Lecanda F; Minguez JA; Alcázar JL; Jurado M
Brachytherapy; 2018; 17(5):734-741. PubMed ID: 29803537
[TBL] [Abstract][Full Text] [Related]
14. Dose volume histogram constraints in patients with soft tissue sarcomas of the extremities and the superficial trunk treated with surgery and perioperative HDR brachytherapy.
Gómez-Álvarez J; Martín Pastor S; Gimeno M; Lamo-Espinosa J; Ramos LI; Cambeiro M; Tagliaferri L; Kovacs G; Strnad V; San-Julián M; Martinez-Monge R
Radiother Oncol; 2022 May; 170():159-164. PubMed ID: 35227732
[TBL] [Abstract][Full Text] [Related]
15. Equivalent uniform dose, D(90), and V(100) correlation with biochemical control after low-dose-rate prostate brachytherapy for clinically low-risk prostate cancer.
Miles EF; Nelson JW; Alkaissi AK; Das S; Clough RW; Anscher MS; Oleson JR
Brachytherapy; 2008; 7(2):206-11. PubMed ID: 18359669
[TBL] [Abstract][Full Text] [Related]
16. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
[TBL] [Abstract][Full Text] [Related]
17. Feasibility report of conservative surgery, perioperative high-dose-rate brachytherapy (PHDRB), and low-to-moderate dose external beam radiation therapy (EBRT) in pediatric sarcomas.
Martínez-Monge R; Garrán C; Cambeiro M; San Julián M; Alcalde J; Sierrasesúmaga L
Brachytherapy; 2004; 3(4):196-200. PubMed ID: 15607151
[TBL] [Abstract][Full Text] [Related]
18. Comparison of limited-volume perioperative high-dose-rate brachytherapy and wide-field external irradiation in resected head and neck cancer.
Gaztañaga M; Pagola M; Cambeiro M; Rodriguez Ruiz ME; Aristu J; Montesdeoca N; Alcalde J; Martínez-Monge R
Head Neck; 2012 Aug; 34(8):1081-8. PubMed ID: 22267124
[TBL] [Abstract][Full Text] [Related]
19. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
20. Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: predictive factors for local control and late toxicity?
Melzner WJ; Lotter M; Sauer R; Strnad V
Radiother Oncol; 2007 Feb; 82(2):167-73. PubMed ID: 17258340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
